Skip to main content
. 2021 Aug 30;9:712196. doi: 10.3389/fcell.2021.712196

FIGURE 1.

FIGURE 1

Workflow of MS analysis from urinary proteomics based on machine learning for distinguishing between benign and malignant ovarian tumors.